About Cosmas
Cosmas is a Healthcare company based in Ludhiana (India) founded in 2013. It operates as a drug formulation unit for pharmaceutical needs. It operates on a B2B model. The company has 27 employees. Its focus areas include Pharmaceuticals, Drug Development and Formulation. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Cosmas, established in 2013, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and formulation. Operates as a drug formulation unit for pharmaceutical needs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Annual Revenue$6.64 M (USD)0as on Mar 31, 2022
- Employee Count27
Associated legal entities of Cosmas
Cosmas is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cosmas Pharmacls Limited CIN U24232PB2010PLC033534 | Active | 22 Jan 2010 | Ludhiana, Punjab | ₹24.0 Cr | 7 | 9 | View details |
| Cosmas Research Lab Limited CIN U24110PB2008PLC031925 | Active | 14 May 2008 | Ludhiana, Punjab | ₹93.4 Cr | 23 | 5 | View details |
Board of directors of Cosmas
The boards of the 2 registered companies of Cosmas currently have 9 directors; the longest-serving is Punit Jain, appointed in 2010. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Punit Jain DIN 01159507 | Managing Director | 22 Jan 2010 | 16 yrs 8 mo | Cosmas Pharmacls Limited, Cosmas Research Lab Limited |
| Sanjay Kumar Jain DIN 01159627 | Whole-time director | 22 Jan 2010 | 16 yrs 8 mo | Cosmas Pharmacls Limited, Cosmas Research Lab Limited |
| Manu Jain DIN 01159674 | Whole-time director | 22 Jan 2010 | 16 yrs 8 mo | Cosmas Pharmacls Limited, Cosmas Research Lab Limited |
| Tanuj Kumar Jain DIN 01159801 | Whole-time director | 22 Jan 2010 | 16 yrs 8 mo | Cosmas Pharmacls Limited, Cosmas Research Lab Limited |
| Tapan Kumar Pal DIN 03006943 | Director | 24 Mar 2010 | 16 yrs 6 mo | Cosmas Pharmacls Limited |
| Tilak Raj Bhardwaj DIN 02984222 | Director | 24 Mar 2010 | 16 yrs 6 mo | Cosmas Pharmacls Limited |
| Ram Rattan Garg DIN 03025128 | Director | 07 Apr 2010 | 16 yrs 6 mo | Cosmas Pharmacls Limited |
| Parkash Chopra DIN 03028800 | Director | 13 Apr 2010 | 16 yrs 6 mo | Cosmas Pharmacls Limited |
| Kuldip Singh DIN 03083843 | Director | 02 Jun 2010 | 16 yrs 4 mo | Cosmas Pharmacls Limited |
Financials of Cosmas
Figures of Cosmas Pharmacls Limited, the primary company behind Cosmas, for FY 2025. Revenue was ₹23.95 Cr (+1% year on year). Net profit was ₹7.7 Lakh (0% margin). EBITDA was ₹4.97 Cr (21% margin). Revenue has grown at a compounded annual rate of +1% over three years and 0% over five years.
- ₹23.95 CrRevenue · FY 2025 · +1% YoY
- ₹7.7 LakhNet profit · 0% margin
- ₹4.97 CrEBITDA · 21% margin
- ₹11.00 CrPaid-up capital
- 7Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cosmas Pharmacls Limited are on its company page.
Detailed financial statements for Cosmas
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Cosmas
Cosmas has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Cosmas
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Cosmas (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cosmas
Cosmas was founded in 2013.
Cosmas is headquartered in Ludhiana, India. It is registered at Ludhiana, Punjab, India.
Cosmas has 27 employees.
Annual revenue of Cosmas is $6.64M as on Mar 31, 2022.
Cosmas, established in 2013, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and formulation. Operates as a drug formulation unit for pharmaceutical needs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Cosmas's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Cosmas is associated with 2 legal entities: Cosmas Pharmacls Limited, Cosmas Research Lab Limited.
The legal entities of Cosmas currently have 9 directors, including Punit Jain, Sanjay Kumar Jain, Manu Jain and others.